(OSIS) OSI Systems - Overview
Sector: Technology | Industry: Electronic Components | Exchange: NASDAQ (USA) | Market Cap: 4.678m USD | Total Return: 54.1% in 12m
Security Systems, Healthcare Devices, Electronic Components
Total Rating 66
Safety 88
Buy Signal 0.92
Electronic Components
Industry Rotation: +22.1
Industry Rotation: +22.1
Market Cap:
4.68B
Avg Turnover: 75.8M USD
Avg Turnover: 75.8M USD
ATR:
4.42%
Peers RS (IBD): 52.9
Peers RS (IBD): 52.9
Risk 5d forecast
Volatility37.7%
Rel. Tail Risk-5.02%
Reward TTM
Sharpe Ratio1.38
Alpha16.42
Character TTM
Beta1.372
Beta Downside1.636
Drawdowns 3y
Max DD23.72%
CAGR/Max DD1.78
EPS (Earnings per Share)
EPS CAGR: 17.04%
EPS Trend: 47.5%
EPS Trend: 47.5%
Last SUE: 0.22
Qual. Beats: 0
Qual. Beats: 0
Revenue
Rev. CAGR: 13.31%
Rev. Trend: 71.7%
Rev. Trend: 71.7%
Last SUE: 0.30
Qual. Beats: 0
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Description: OSIS OSI Systems
OSI Systems, Inc. (OSIS) designs and manufactures electronic systems and components. The company operates across three segments: Security, Healthcare, and Optoelectronics and Manufacturing.
The Security segment provides inspection and detection systems for baggage, cargo, and people under the Rapiscan brand. This sector is heavily influenced by government regulations and global security concerns.
The Healthcare segment offers patient monitoring and connected care systems through its Spacelabs brand, serving hospitals and clinics. The medical device industry is characterized by long product development cycles and stringent regulatory approvals.
The Optoelectronics and Manufacturing segment supplies optoelectronic devices, flexible circuits, and electronics manufacturing services under various brands, catering to diverse industries including aerospace, medical, and defense. This business model often involves high-precision manufacturing and custom solutions.
To deepen your understanding of OSISs market position, consider exploring its competitive landscape and financial performance on ValueRay.
- Global security infrastructure spending impacts Rapiscan system demand
- Healthcare capital expenditure drives Spacelabs equipment sales
- Optoelectronics component demand tied to industrial and defense sectors
- Supply chain disruptions increase manufacturing costs
- Government contract awards significantly influence Security segment revenue
Piotroski VR‑10 (Strict)
7.5
| Net Income: 153.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 9.78 > 1.0 |
| NWC/Revenue: 64.04% < 20% (prev 39.08%; Δ 24.96% < -1%) |
| CFO/TA 0.06 > 3% & CFO 161.5m > Net Income 153.1m |
| Net Debt (667.2m) to EBITDA (262.5m): 2.54 < 3 |
| Current Ratio: 3.15 > 1.5 & < 3 |
| Outstanding Shares: last quarter (17.5m) vs 12m ago 2.52% < -2% |
| Gross Margin: 33.00% > 18% (prev 0.34%; Δ 3.27k% > 0.5%) |
| Asset Turnover: 77.28% > 50% (prev 74.56%; Δ 2.72% > 0%) |
| Interest Coverage Ratio: 6.50 > 6 (EBITDA TTM 262.5m / Interest Expense TTM 34.0m) |
Altman Z''
5.28
| A: 0.46 (Total Current Assets 1.69b - Total Current Liabilities 535.4m) / Total Assets 2.52b |
| B: 0.34 (Retained Earnings 862.0m / Total Assets 2.52b) |
| C: 0.10 (EBIT TTM 221.1m / Avg Total Assets 2.33b) |
| D: 0.50 (Book Value of Equity 845.5m / Total Liabilities 1.68b) |
| Altman-Z'' Score: 5.28 = AAA |
Beneish M
-2.94
| DSRI: 1.05 (Receivables 833.2m/703.9m, Revenue 1.80b/1.59b) |
| GMI: 1.04 (GM 33.00% / 34.27%) |
| AQI: 0.88 (AQ_t 0.28 / AQ_t-1 0.32) |
| SGI: 1.13 (Revenue 1.80b / 1.59b) |
| TATA: -0.00 (NI 153.1m - CFO 161.5m) / TA 2.52b) |
| Beneish M-Score: -2.94 (Cap -4..+1) = A |
What is the price of OSIS shares?
As of April 10, 2026, the stock is trading at USD 294.48 with a total of 178,107 shares traded.
Over the past week, the price has changed by +9.84%, over one month by +4.37%, over three months by +5.58% and over the past year by +54.05%.
Over the past week, the price has changed by +9.84%, over one month by +4.37%, over three months by +5.58% and over the past year by +54.05%.
Is OSIS a buy, sell or hold?
OSI Systems has received a consensus analysts rating of 4.43.
Therefore, it is recommended to buy OSIS.
- StrongBuy: 4
- Buy: 2
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the OSIS price?
| Analysts Target Price | 300 | 1.9% |
OSI Systems (OSIS) - Fundamental Data Overview
as of 09 April 2026
P/E Trailing = 31.2061 P/E Forward = 23.4742
P/S = 2.6019
P/B = 5.2225
P/EG = 1.9569
Revenue TTM = 1.80b USD
EBIT TTM = 221.1m USD
EBITDA TTM = 262.5m USD
Long Term Debt = 998.9m USD (from longTermDebt, last quarter)
Short Term Debt = 5.05m USD (from shortTermDebt, last quarter)
Debt = 1.00b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 667.2m USD (from netDebt column, last quarter)
Enterprise Value = 5.35b USD (4.68b + Debt 1.00b - CCE 336.7m)
Interest Coverage Ratio = 6.50 (Ebit TTM 221.1m / Interest Expense TTM 34.0m)
EV/FCF = 37.56x (Enterprise Value 5.35b / FCF TTM 142.3m)
FCF Yield = 2.66% (FCF TTM 142.3m / Enterprise Value 5.35b)
FCF Margin = 7.92% (FCF TTM 142.3m / Revenue TTM 1.80b)
Net Margin = 8.52% (Net Income TTM 153.1m / Revenue TTM 1.80b)
Gross Margin = 33.00% ((Revenue TTM 1.80b - Cost of Revenue TTM 1.20b) / Revenue TTM)
Gross Margin QoQ = 32.67% (prev 32.03%)
Tobins Q-Ratio = 2.12 (Enterprise Value 5.35b / Total Assets 2.52b)
Interest Expense / Debt = 1.07% (Interest Expense 10.7m / Debt 1.00b)
Taxrate = 19.51% (9.38m / 48.1m)
NOPAT = 178.0m (EBIT 221.1m * (1 - 19.51%))
Current Ratio = 3.15 (Total Current Assets 1.69b / Total Current Liabilities 535.4m)
Debt / Equity = 1.19 (Debt 1.00b / totalStockholderEquity, last quarter 845.5m)
Debt / EBITDA = 2.54 (Net Debt 667.2m / EBITDA 262.5m)
Debt / FCF = 4.69 (Net Debt 667.2m / FCF TTM 142.3m)
Total Stockholder Equity = 905.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.58% (Net Income 153.1m / Total Assets 2.52b)
RoE = 16.91% (Net Income TTM 153.1m / Total Stockholder Equity 905.5m)
RoCE = 11.61% (EBIT 221.1m / Capital Employed (Equity 905.5m + L.T.Debt 998.9m))
RoIC = 10.79% (NOPAT 178.0m / Invested Capital 1.65b)
WACC = 9.05% (E(4.68b)/V(5.68b) * Re(10.81%) + D(1.00b)/V(5.68b) * Rd(1.07%) * (1-Tc(0.20)))
Discount Rate = 10.81% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.48%
[DCF] Terminal Value 66.03% ; FCFF base≈142.3m ; Y1≈93.4m ; Y5≈42.7m
[DCF] Fair Price = 2.85 (EV 714.2m - Net Debt 667.2m = Equity 47.0m / Shares 16.5m; r=9.05% [WACC]; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 47.49 | EPS CAGR: 17.04% | SUE: 0.22 | # QB: 0
Revenue Correlation: 71.70 | Revenue CAGR: 13.31% | SUE: 0.30 | # QB: 0
EPS current Year (2026-06-30): EPS=10.46 | Chg7d=+0.000 | Chg30d=+0.041 | Revisions Net=+2 | Growth EPS=+11.7% | Growth Revenue=+7.7%
EPS next Year (2027-06-30): EPS=11.52 | Chg7d=+0.000 | Chg30d=+0.129 | Revisions Net=+5 | Growth EPS=+10.2% | Growth Revenue=+5.5%
[Analyst] Revisions Ratio: +0.33 (4 Up / 2 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 7.6% (Discount Rate 10.8% - Earnings Yield 3.2%)
[Growth] Growth Spread = -2.1% (Analyst 5.5% - Implied 7.6%)
External Resources